Heart patients who had undergone an angioplasty procedure that opened only some blocked arteries tended to have a resolution of their chest pain, making it unnecessary to add another medication to treat the symptom, according ...
Nov 11, 2015
0
17
A decline in the number of heart patients undergoing unnecessary PCI (angioplasty) procedures reflects improvements in clinical decision-making and documentation to determine which patients benefit most from the procedure, ...
Nov 9, 2015
0
1
Nihar R. Desai, M.D., M.P.H., of the Yale School of Medicine, New Haven, Conn., and colleagues examined trends in percutaneous coronary intervention use, patient selection, and procedural appropriateness following the introduction ...
Nov 9, 2015
0
2
(HealthDay)—For select patients with ST-segment elevation myocardial infarction (STEMI) with multivessel disease undergoing percutaneous coronary intervention (PCI), PCI in the noninfarct artery should be considered, according ...
Oct 22, 2015
0
8
Patients with acute coronary syndrome who have undergone angioplasty have a reduced risk of all-cause in-hospital mortality but an increased risk of bleeding when given glycoprotein 2b/3a inhibitors (GPI) after the procedure, ...
Oct 19, 2015
0
5
A simple, low-cost automated program of semi-personalized mobile phone text messages supporting lifestyle change led to improvement in low-density lipoprotein cholesterol (LDL-C) levels, blood pressure, body mass index, and ...
Sep 22, 2015
0
5
A drug-eluting coronary stent made of absorbable material performed similarly to the gold-standard metal one in a non-inferiority trial among patients with the more serious type of heart attack known as ST-segment elevation ...
Sep 1, 2015
0
9
Extending treatment with the anticoagulant bivalirudin for at least four hours after completion of percutaneous coronary intervention (PCI) does not improve outcomes compared to stopping the treatment immediately after the ...
Sep 1, 2015
0
10
An investigational material known Bioabsorbable Cardiac Matrix (BCM) that is injected through the coronary artery to prevent cardiac remodelling in heart attack patients had no significant effect compared to a saline placebo, ...
Sep 1, 2015
0
3
Extending clot-preventing dual antiplatelet therapy (DAPT) beyond the recommended 12 months after coronary stenting "should be considered" in patients at low risk for bleeding, investigators for the OPTIDUAL trial recommend.
Sep 1, 2015
0
6
